Minerva Neurosciences, Inc. (NERV) bonds
NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$2.16−0.04 (-1.82%)
Close on Nov 17, 2026Market cap $103.14MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Minerva Neurosciences reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Minerva Neurosciences's 10-Q for the period ended Jan 15, 2016
Minerva Neurosciences's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Loan and Security Agreement | $15.00M |
See a number that looks wrong?